Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients.

BACKGROUND/AIM In oncology, elderly people are a separate group of patients requiring special consideration. This applies to the treatment of cerebral metastases as well. The present study focused on elderly patients receiving stereotactic radiosurgery (SRS) for few cerebral lesions. PATIENTS AND METHODS In 95 patients aged ≥65 years, two SRS doses, 16-18 Gy (n=44) and 20 Gy (n=51), were compared regarding outcomes of SRS. RESULTS The overall intracerebral control rates at 12 months were 30% after 16-18 Gy and 45% after 20 Gy (p=0.53). Twelve-month rates of freedom from new intracerebral lesions were 41% and 52%, respectively (p=0.63). Twelve-month local control rates of the irradiated lesions were 55% and 81%, respectively (p=0.069). Overall survival rates at 12 months were 29% and 31%, respectively (p=0.67). CONCLUSION SRS with 16-18 Gy was not significantly inferior to SRS with 20 Gy in elderly patients with few cerebral metastases.

[1]  A. Kallianos,et al.  Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection , 2015, In vivo.

[2]  D. Rades,et al.  Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer , 2014, BMC Cancer.

[3]  D. Rades,et al.  Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer. , 2014, Anticancer research.

[4]  Carlo Riccardo Rossi,et al.  Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. , 2014, In vivo.

[5]  A. Vogel,et al.  First-line nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer from routine clinical practice. , 2014, In vivo.

[6]  A. Ghobadi,et al.  Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients. , 2014, Anticancer research.

[7]  D. Rades,et al.  A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone , 2014, Radiation oncology.

[8]  C. Borgfeldt,et al.  Elderly women above screening age diagnosed with cervical cancer have a worse prognosis. , 2014, Anticancer research.

[9]  O. Guerin,et al.  Granulocyte-colony-stimulating factor in elderly patients receiving chemotherapy for breast and gynaecological cancers: results of a French survey. , 2014, Anticancer research.

[10]  S. Scarpa,et al.  Elderly woman with triple-negative metastatic breast cancer successfully treated with metronomic capecitabine. , 2014, Anticancer research.

[11]  F. Pasqualetti,et al.  Radio-chemotherapy with temozolomide in elderly patients with glioblastoma. A mono-institutional experience. , 2014, Anticancer research.

[12]  D. Rades,et al.  Stereotactic radiosurgery for newly diagnosed brain metastases , 2014, Strahlentherapie und Onkologie.

[13]  R. Tozzoli,et al.  Circulating PTH, Vitamin D and IGF-I levels in relation to bone mineral density in elderly women. , 2013, In vivo.

[14]  K. Hess,et al.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. , 2009, The Lancet. Oncology.

[15]  D. Rades,et al.  A New Scoring System to Predicting the Survival of Patients Treated with Whole-Brain Radiotherapy for Brain Metastases , 2008, Strahlentherapie und Onkologie.

[16]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[17]  D. Rades,et al.  Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses. , 2015, Anticancer research.